,Castillo/Werner-McCullough:iCalculatingiDrugiDosages:iAiPatient-SafeiApproachitoiNursingiandiMath,,2e
TestiBank
TableiofiContents:
I.iSafetyiiniMedicationiAdministration
Chapteri1.iSafetyiiniMedicationiAdministration
Chapteri2.iTheiDrugiLabel
II.iSystemsiofiMeasurement
Chapteri3.iTheiMetriciSystem
Chapteri4.iTheiHouseholdiSystem
III.iMethodsiofiCalculation
Chapteri5.iLineariRatioiandiProportion
Chapteri6.iFractionaliRatioiandiProportion
Chapteri7.iDimensionaliAnalysis
Chapteri8.iFormulaiMethod
IV.iAdministrationiofiMedications
Chapteri9.iCalculatingiOraliMedicationiDoses
Chapteri10.iSyringesiandiNeedles
Chapteri11.iCalculatingiParenteraliMedicationiDosages
Chapteri12.iPreparingiPowderediParenteraliMedications
Chapteri13.iAdministrationiofiInsulin
V.iIViTherapyiandiAdministrationiofiIntravenousiMedications
Chapteri14.iIntravenousiInfusioniandiInfusioniRates
Chapteri15.iCalculatingiInfusioniandiCompletioniTime
Chapteri16.iAdministeringiIViPushiMedications
VI.iVerifyingiSafeiDoseiandiCriticaliCareiCalculations
Chapteri17.iVerifyingiSafeiDose
Chapteri18.iTitrationiofiIntravenousiMedications
VII.iIntakeiandiOutput
Chapteri19.iCalculatingiIntakeiandiOutput
Chapteri20.iCalculatingiParenteraliIntake
VIII.iDosagesiforiPediatriciandiOlderiAdultiPopulations
Chapteri21.iConsiderationsiforitheiPediatriciPatient
Chapteri22.iConsiderationsiforitheiOlderiAdult
,Castillo/Werner-McCullough:iCalculatingiDrugiDosages,i2e
Chapteri1:iSafetyiiniMedicationiAdministration
Castillo:iCalculatingiDrugiDosages:iAiPatient-SafeiApproachitoiNursingiandiMathi2ndiEdition
MULTIPLEiCHOICE
1. Theifollowingimedicationiorderiisiinitheipatient’simedicationiadministrationirecordi(MAR):
methylPREDnisolonei40imgiPOidailyiati0900.
Afterireadingitheiorder,itheinurseicorrectlyidetermines:
A “PO”iisianiinappropriateiabbreviation.
B theimedicationiorderiisiwrittenicorrectly.
C 40imgishouldibeiwritteniasi40mg.
D tallimaniletteringiindicatesithatitheidrugiisiainarcotic.
ANS:iB
Feedback
Theimedicationiorderihasiallitheirequiredicomponentsi(druginame,idose,iroute,iandifr
equencyiofiadministration)iforiaidrugiorder.i“PO”iisianiappropriateiabbreviation;i40i
mgiisiwrittenicorrectlyiwithiaispaceibetweenitheidoseianditheiunitiofimeasurement.iT
allimaniletteringiisiuseditoidistinguishitheidrugifromianotheridrug
withiaisimilariname.
2. Whichiofitheifollowingiaccuratelyidescribesithei“BoxediWarning”ifoundioniaidrugilabel?
A Itiisiprimarilyiisiuseditoiidentifyitheisafeidoseiforitheipatient.
B Itiisicommonlyifoundioniallidrugilabels.
C Itiidentifiesiseriousipotentialirisksiandisideieffectsirelateditoidrugiuse.
D Itiprotectsitheipatientibyiprovidingiinformationitoidecreaseisideieffects.
ANS:iC
Feedback
Aidrugilabeliwithiaiboxediwarningiprovidesiinformationitoihealthcareiprofessionalsia
ndipatientsiregardingitheiseriousirisksiandisideieffectsirelateditoitheidrug.iTheiBoxedi
Warningiisinotitheiprimaryisourceiforiidentifyingitheipatient’sidrugidosage.
Theiwarningiisifoundionispecificiprescriptionimedicationsiandidoesinotiprovideiin
formationitoireduceioridecreaseisideieffects.
3. Whenipracticingisafetyiinitheiadministrationiofimedication,iforiwhichiofitheifollowingim
edicationiordersishouldiainurseiseekiclarificationibeforeitheiadministrationiofitheimedic
ation?
1
, Castillo/Werner-McCullough:iCalculatingiDrugiDosages,i2e
A Regulariinsulini5iuisubcutinow.
B Enoxaparini80imgisubcutieveryi12ihours.
C Benadryli50imgiPOiPRNieveryi6ihriforiitching.
D Ondansetroni4imgiIVPistat.
ANS:iA
Feedback
Thei“u”ishouldineveribeiusediiniaimedicationiorder;irather,iforisafety,itheiwordi“u
nits”ishouldibeispellediout.iTheiotherianswerioptionsicontainitheirequired
componentsineededitoisafelyicarryioutitheimedicationiorder.
4. Ainurseiisireviewingiaidrugilabeliwithiaidruginameiwritteniwithitallimanilettering.iWhichistate
mentsishowsitheinurseihasiaicorrectiunderstandingiofitallimaniletteringioniaidrugilabel?
A “Theitallimaniletteringimeansithisiisiaihighialertidrug.”
B “Theitallimaniletteringihelpsimeidistinguishithisidrugiwithiotheridrugsithat
haveisimilarinames.”
C “TheitallimaniletteringimeansithatithisidrugimustihaveiaiBoxediWarning.”
D “Theitallimaniletteringihelpsimeiquicklyiidentifyithatithisidrugiisianiinjectable
drug.”
ANS:iB
Feedback
Tallimaniletteringihighlightsiaiportioniofitheidruginameitoihelpidistinguishifromisi
milaridruginames.iItiisinotiuseditoiidentifyihighialertidrugs,ihighlightiaiboxed
warning,ioriidentifyiinjectableidrugs.
5. Theifollowingimedicationiordersiareifoundiinitheipatient’siMAR:
MetforminiHCli500imgiPOidailyiati0900.iHydrochlorothiazid
ei25imgiPOieveryi12ihriati0900iandi2100.iDigoxini.25imgiPOida
ilyiati0900.
Inireadingitheimedicationiordersiforithei0700–
1500ishift,itheinurseideterminesithatiwhichiofitheifollowingiisitheipriorityinursingiintervention
?
A ClarifyitheimetforminiHCliorder.
B Clarifyitheihydrochlorothiazideiorder.
C Clarifyitheidigoxiniorder.
D Prepareitoiadministerithei0900imedications.
ANS:iC
2
TestiBank
TableiofiContents:
I.iSafetyiiniMedicationiAdministration
Chapteri1.iSafetyiiniMedicationiAdministration
Chapteri2.iTheiDrugiLabel
II.iSystemsiofiMeasurement
Chapteri3.iTheiMetriciSystem
Chapteri4.iTheiHouseholdiSystem
III.iMethodsiofiCalculation
Chapteri5.iLineariRatioiandiProportion
Chapteri6.iFractionaliRatioiandiProportion
Chapteri7.iDimensionaliAnalysis
Chapteri8.iFormulaiMethod
IV.iAdministrationiofiMedications
Chapteri9.iCalculatingiOraliMedicationiDoses
Chapteri10.iSyringesiandiNeedles
Chapteri11.iCalculatingiParenteraliMedicationiDosages
Chapteri12.iPreparingiPowderediParenteraliMedications
Chapteri13.iAdministrationiofiInsulin
V.iIViTherapyiandiAdministrationiofiIntravenousiMedications
Chapteri14.iIntravenousiInfusioniandiInfusioniRates
Chapteri15.iCalculatingiInfusioniandiCompletioniTime
Chapteri16.iAdministeringiIViPushiMedications
VI.iVerifyingiSafeiDoseiandiCriticaliCareiCalculations
Chapteri17.iVerifyingiSafeiDose
Chapteri18.iTitrationiofiIntravenousiMedications
VII.iIntakeiandiOutput
Chapteri19.iCalculatingiIntakeiandiOutput
Chapteri20.iCalculatingiParenteraliIntake
VIII.iDosagesiforiPediatriciandiOlderiAdultiPopulations
Chapteri21.iConsiderationsiforitheiPediatriciPatient
Chapteri22.iConsiderationsiforitheiOlderiAdult
,Castillo/Werner-McCullough:iCalculatingiDrugiDosages,i2e
Chapteri1:iSafetyiiniMedicationiAdministration
Castillo:iCalculatingiDrugiDosages:iAiPatient-SafeiApproachitoiNursingiandiMathi2ndiEdition
MULTIPLEiCHOICE
1. Theifollowingimedicationiorderiisiinitheipatient’simedicationiadministrationirecordi(MAR):
methylPREDnisolonei40imgiPOidailyiati0900.
Afterireadingitheiorder,itheinurseicorrectlyidetermines:
A “PO”iisianiinappropriateiabbreviation.
B theimedicationiorderiisiwrittenicorrectly.
C 40imgishouldibeiwritteniasi40mg.
D tallimaniletteringiindicatesithatitheidrugiisiainarcotic.
ANS:iB
Feedback
Theimedicationiorderihasiallitheirequiredicomponentsi(druginame,idose,iroute,iandifr
equencyiofiadministration)iforiaidrugiorder.i“PO”iisianiappropriateiabbreviation;i40i
mgiisiwrittenicorrectlyiwithiaispaceibetweenitheidoseianditheiunitiofimeasurement.iT
allimaniletteringiisiuseditoidistinguishitheidrugifromianotheridrug
withiaisimilariname.
2. Whichiofitheifollowingiaccuratelyidescribesithei“BoxediWarning”ifoundioniaidrugilabel?
A Itiisiprimarilyiisiuseditoiidentifyitheisafeidoseiforitheipatient.
B Itiisicommonlyifoundioniallidrugilabels.
C Itiidentifiesiseriousipotentialirisksiandisideieffectsirelateditoidrugiuse.
D Itiprotectsitheipatientibyiprovidingiinformationitoidecreaseisideieffects.
ANS:iC
Feedback
Aidrugilabeliwithiaiboxediwarningiprovidesiinformationitoihealthcareiprofessionalsia
ndipatientsiregardingitheiseriousirisksiandisideieffectsirelateditoitheidrug.iTheiBoxedi
Warningiisinotitheiprimaryisourceiforiidentifyingitheipatient’sidrugidosage.
Theiwarningiisifoundionispecificiprescriptionimedicationsiandidoesinotiprovideiin
formationitoireduceioridecreaseisideieffects.
3. Whenipracticingisafetyiinitheiadministrationiofimedication,iforiwhichiofitheifollowingim
edicationiordersishouldiainurseiseekiclarificationibeforeitheiadministrationiofitheimedic
ation?
1
, Castillo/Werner-McCullough:iCalculatingiDrugiDosages,i2e
A Regulariinsulini5iuisubcutinow.
B Enoxaparini80imgisubcutieveryi12ihours.
C Benadryli50imgiPOiPRNieveryi6ihriforiitching.
D Ondansetroni4imgiIVPistat.
ANS:iA
Feedback
Thei“u”ishouldineveribeiusediiniaimedicationiorder;irather,iforisafety,itheiwordi“u
nits”ishouldibeispellediout.iTheiotherianswerioptionsicontainitheirequired
componentsineededitoisafelyicarryioutitheimedicationiorder.
4. Ainurseiisireviewingiaidrugilabeliwithiaidruginameiwritteniwithitallimanilettering.iWhichistate
mentsishowsitheinurseihasiaicorrectiunderstandingiofitallimaniletteringioniaidrugilabel?
A “Theitallimaniletteringimeansithisiisiaihighialertidrug.”
B “Theitallimaniletteringihelpsimeidistinguishithisidrugiwithiotheridrugsithat
haveisimilarinames.”
C “TheitallimaniletteringimeansithatithisidrugimustihaveiaiBoxediWarning.”
D “Theitallimaniletteringihelpsimeiquicklyiidentifyithatithisidrugiisianiinjectable
drug.”
ANS:iB
Feedback
Tallimaniletteringihighlightsiaiportioniofitheidruginameitoihelpidistinguishifromisi
milaridruginames.iItiisinotiuseditoiidentifyihighialertidrugs,ihighlightiaiboxed
warning,ioriidentifyiinjectableidrugs.
5. Theifollowingimedicationiordersiareifoundiinitheipatient’siMAR:
MetforminiHCli500imgiPOidailyiati0900.iHydrochlorothiazid
ei25imgiPOieveryi12ihriati0900iandi2100.iDigoxini.25imgiPOida
ilyiati0900.
Inireadingitheimedicationiordersiforithei0700–
1500ishift,itheinurseideterminesithatiwhichiofitheifollowingiisitheipriorityinursingiintervention
?
A ClarifyitheimetforminiHCliorder.
B Clarifyitheihydrochlorothiazideiorder.
C Clarifyitheidigoxiniorder.
D Prepareitoiadministerithei0900imedications.
ANS:iC
2
